Related Experiment Video
Updated: Jun 6, 2025
07:20
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
407
LSD1 Demethylates and Destabilizes Autophagy Protein LC3B in Ovarian Cancer
Mingyang Li1,2, Jie Feng2, Kangrong Zhao2
1Institute of Urinary System Diseases, The Affiliated People's Hospital, Jiangsu University, 8 Dianli Road, Zhenjiang 212002, China.
Biomolecules
|November 27, 2024
Summary
Lysine-specific demethylase 1 (LSD1) regulates autophagy in ovarian cancer by binding to and decreasing the stability of the autophagy protein LC3B. High LSD1 levels correlate with aggressive ovarian cancer and poor patient survival.
Area of Science:
- Cellular Biology
- Oncology
- Biochemistry
Background:
- Autophagy plays a dual role in cancer, potentially promoting or inhibiting tumor progression.
- The molecular mechanisms governing autophagy in ovarian cancer require further elucidation.
- Lysine-specific demethylase 1 (LSD1) is implicated in various cancers, but its role in ovarian cancer autophagy is not well understood.
Purpose of the Study:
- To investigate the regulatory role of LSD1 in autophagy within ovarian cancer.
- To determine the interaction between LSD1 and the autophagy protein LC3B.
- To explore the clinical significance of the LSD1-LC3B axis in ovarian cancer progression.
Main Methods:
- Bioinformatic analysis of TCGA, CPTAC, and GEO datasets.
- Immunohistochemistry on ovarian cancer patient samples.
- Western blotting, immunoprecipitation, and GST pull-down assays to analyze molecular mechanisms.
Main Results:
- LSD1 directly binds to LC3B through its SWIRM domain.
- High LSD1 expression is associated with aggressive ovarian cancer and poorer patient outcomes.
- LSD1 demethylates LC3B, leading to reduced LC3B protein stability.
Conclusions:
- LSD1 negatively regulates LC3B protein levels in ovarian cancer via demethylation.
- The observed inverse correlation between LSD1 and LC3B suggests a role for LSD1 in promoting ovarian cancer aggressiveness.
- Further research is warranted to understand the clinical implications of LSD1-mediated LC3B downregulation in ovarian cancer.
More Related Videos
Related Concept Videos
01:36Delivery Pathways to the Lysosome
6.2K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K
01:27Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:18Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:31The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K